Assure Announces Further Extension of Exchange Offer Relating to its Convertible Notes
August 19 2024 - 7:00AM
Assure Holdings Corp. (“Assure” or the “Company”) (OTC: IONM),
today announced that it has extended the expiration date of its
exchange offer (the “Offer”) relating to the Company’s 9%
Convertible Debentures due 2023 and 2024 (the “Assure Convertible
Debentures”). As a result of the extension, the Exchange Offer is
now scheduled to expire at 11:59 p.m. (Denver Time),
on August 23, 2024 (the “Expiration Date”) unless further
extended.
The Offer was originally scheduled to expire at
11:59 p.m. (Denver Time) on July 19, 2024, and has been extended
several times to now expire at 11:59 p.m. (Denver Time), on August
23, 2024. Except for the extension of the Expiration Date, all of
the other terms of the Offer remain as set forth in the Offer
Letter dated June 21, 2024, as amended (the “Offer Letter”),
and a Schedule TO related thereto, as filed with the U.S.
Securities and Exchange Commission (“SEC”) on June 21, 2024,
as amended (the “Schedule TO”).
As of 11:59 p.m. (Denver Time) on August 16,
2024, $2.0 million in principal face amount of Assure Convertible
Debentures have been tendered into the Offer.
Important Information Has Been Filed
with the SEC
Copies of the Offer Letter (and all amendments
thereto) and the Schedule TO (and all amendments thereto) are
available free of charge at the website of
the SEC at www.sec.gov. Requests
for documents may also be directed to Assure Holdings Corp.,
7887 E. Belleview Ave., Suite 240, Denver, Colorado, USA 80111 or
email to ir@assureiom.com.
This announcement is for informational purposes
only and shall not constitute an offer to purchase or a
solicitation of an offer to sell the Assure Convertible Notes or an
offer to sell or a solicitation of an offer to buy any shares of
Assure’s common stock. The Offer is being made only through the
Schedule TO and Offer Letter, and the complete terms and conditions
of the Offer are set forth in the Schedule TO and Offer Letter.
Holders of the Assure Convertible Debentures are urged to read the
Schedule TO and Offer Letter carefully before making any decision
with respect to the Offer because they contain important
information, including the various terms of, and conditions to, the
Offer. None of Assure, or any of its management or its board of
directors makes any recommendation as to whether or not holders of
Assure Convertible Debentures should tender such Assure Convertible
Debentures for exchange in the Offer.
About Assure Holdings
Assure Holdings Corp. is a provider of
outsourced intraoperative neuromonitoring and remote neurology
services. The Company delivers a turnkey suite of clinical and
operational services to support surgeons and medical facilities
during invasive procedures that place the nervous system at risk
including neurosurgery, spine, cardiovascular, orthopedic and ear,
nose and throat surgeries. Assure employs highly trained
technologists that provide a direct point of contact in the
operating room. Physicians employed through Assure subsidiaries
simultaneously monitor the functional integrity of patients’ neural
structures throughout the procedure communicating in real-time with
the surgeon and technologist. Accredited by The Joint Commission,
Assure’s mission is to provide exceptional surgical care and a
positive patient experience. For more information, visit the
Company’s website at www.assureneuromonitoring.com.
Forward-Looking Statements
This news release may contain “forward-looking
statements” within the meaning of applicable securities laws.
Forward-looking statements may generally be identified by the use
of the words “anticipates,” “expects,” “intends,” “plans,”
“should,” “could,” “would,” “may,” “will,” “believes,” “estimates,"
“potential,” “target,” or “continue” and variations or similar
expressions. Forward-looking statements include, but are not
limited to, the future expiration date of the Offer, and other
similar statements. These statements are based upon the current
expectations and beliefs of management and are subject to certain
risks and uncertainties that could cause actual results to differ
materially from those described in the forward-looking statements.
These risks include risks regarding our patient volume or cases not
growing as expected, or decreasing, which could impact revenue and
profitability; unfavorable economic conditions could have an
adverse effect on our business; risks related to increased leverage
resulting from incurring additional debt; the policies of health
insurance carriers may affect the amount of revenue we receive; our
ability to successfully market and sell our products and services;
we may be subject to competition and technological risk which may
impact the price and amount of services we can sell and the nature
of services we can provide; regulatory changes that are unfavorable
in the states where our operations are conducted or concentrated;
our ability to comply and the cost of compliance with extensive
existing regulation and any changes or amendments thereto; changes
within the medical industry and third-party reimbursement policies
and our estimates of associated timing and costs with the same; our
ability to adequately forecast expansion and the Company’s
management of anticipated growth; and risks and uncertainties
discussed in our most recent annual and quarterly reports filed
with the United States Securities and Exchange Commission,
including our annual report on Form 10-K filed on April 26, 2024,
and with the Canadian securities regulators and available on the
Company’s profiles on EDGAR at www.sec.gov and SEDAR at
www.sedar.com, which risks and uncertainties are incorporated
herein by reference. Readers are cautioned not to place undue
reliance on forward-looking statements. Except as required by law,
Assure does not intend, and undertakes no obligation, to update any
forward-looking statements to reflect, in particular, new
information or future events.
Investor ContactBrett Maas,
Managing Principal, Hayden IRionm@haydenir.com(646) 536-7331
Source: Assure Holdings Corp.
Assure (NASDAQ:IONM)
Historical Stock Chart
From Nov 2024 to Dec 2024
Assure (NASDAQ:IONM)
Historical Stock Chart
From Dec 2023 to Dec 2024